Drugs With Only 1 Patent Left for Expiry

As certain drugs approach the end of their patent protection, they enter a critical phase where only one patent remains before generic versions can enter the market. This final patent is all that stands between these drugs and potential competition, which could lead to lower prices and greater accessibility. On this page, we highlight the drugs that are down to their last patent, signaling that major changes could be on the way for these medications and their availability.

1. ADDYI

Addyi is a brand drug owned by Sprout Pharmaceuticals Inc. It is Used for treating hypoactive sexual desire disorder (HSDD). It was approved for market use on Aug 18, 2015. Addyi uses Flibanserin as an active ingredient.

Total Patents: 4

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US7151103 Method of treating female hypoactive sexual desire disorder with flibanserin May 09, 2028

Check the entire list of patents and their expiration dates for Addyi

2. ALTABAX

Altabax is a brand drug owned by Almirall Llc. It is Used for treating impetigo caused by Staphylococcus aureus or Streptococcus pyogenes. It was approved for market use on Apr 12, 2007. Altabax uses Retapamulin as an active ingredient.

Total Patents: 4

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US7875630 Process salts compositions and use Feb 14, 2027

Check the entire list of patents and their expiration dates for Altabax

3. ANGELIQ

Angeliq is a brand drug owned by Bayer Healthcare Pharmaceuticals Inc. It was approved for market use on Feb 29, 2012. Angeliq uses Drospirenone; Estradiol as an active ingredient.

Total Patents: 2

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US8906890 Very low-dosed solid oral dosage forms for HRT Oct 22, 2031

Check the entire list of patents and their expiration dates for Angeliq

4. APRISO

Apriso is a brand drug owned by Salix Pharmaceuticals Inc. It is Used for maintaining remission of ulcerative colitis in adults. It was approved for market use on Oct 31, 2008. Apriso uses Mesalamine as an active ingredient.

Total Patents: 7

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US8865688 Compositions and methods for treatment of bowel diseases with granulated mesalamine May 01, 2030

Check the entire list of patents and their expiration dates for Apriso

5. ARICEPT

Aricept is a brand drug owned by Eisai Inc. It was approved for market use on Jul 23, 2010. Aricept uses Donepezil Hydrochloride as an active ingredient.

Total Patents: 4

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US8481565 Method for stabilizing anti-dementia drug Oct 04, 2026

Check the entire list of patents and their expiration dates for Aricept

6. ATROVENT HFA

Atrovent Hfa is a brand drug owned by Boehringer Ingelheim Pharmaceuticals Inc. It was approved for market use on Nov 27, 2004. Atrovent Hfa uses Ipratropium Bromide as an active ingredient.

Total Patents: 5

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US8474447 Inhaler device Jan 17, 2030

Check the entire list of patents and their expiration dates for Atrovent Hfa

7. BALCOLTRA

Balcoltra is a brand drug owned by Avion Pharmaceuticals Llc. It is Used for treating iron deficiency. It was approved for market use on Jan 9, 2018. Balcoltra uses Ethinyl Estradiol; Levonorgestrel as an active ingredient.

Total Patents: 2

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US7838042 Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions Jun 01, 2027

Check the entire list of patents and their expiration dates for Balcoltra

8. BEPREVE

Bepreve is a brand drug owned by Bausch And Lomb Inc. It was approved for market use on Sep 8, 2009. Bepreve uses Bepotastine Besilate as an active ingredient.

Total Patents: 3

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US8784789 Aqueous liquid preparations and light-stabilized aqueous liquid preparations Jan 13, 2025

Check the entire list of patents and their expiration dates for Bepreve

9. BINOSTO

Binosto is a brand drug owned by Radius Health Inc. It is used for treating symptoms of depression and anxiety It was approved for market use on Mar 12, 2012. Binosto uses Alendronate Sodium as an active ingredient.

Total Patents: 3

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US9592195 Stable effervescent bisphosphonate formulations with rapid solubilization characteristics Dec 05, 2031

Check the entire list of patents and their expiration dates for Binosto

10. CHILDREN'S ALLEGRA ALLERGY

Children's Allegra Allergy is a brand drug owned by Chattem Inc Dba Sanofi Consumer Healthcare. It is used for relieving symptoms associated with respiratory allergies and hives in adults and children. It was approved for market use on Jan 24, 2011. Children's Allegra Allergy uses Fexofenadine Hydrochloride as an active ingredient.

Total Patents: 19

Remaining 1 active patent -

Drug Patent Number Drug Patent Title Drug Patent Expiry
US8933097 Fexofenadine suspension formulation Aug 02, 2030

Check the entire list of patents and their expiration dates for Children's Allegra Allergy

Download full list of 50+ drugs as PDF

Have Questions?

Filter drugs by